Review



computer-generated randomisation code  (Novartis)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novartis computer-generated randomisation code
    Computer Generated Randomisation Code, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pm12765508-76-17-21
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Random sequence generation (selection bias) , Low risk , "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma". .. Allocation concealment (selection bias) , Low risk , Not described Comment: likely to be low risk since this is a large multicentre trial.

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Adverse events Source of funding Novartis Pharma Declaration of interest Sponsored by Novartis Pharma Notes Main hypothesis: to assess the effects of rivastigmine on the core domains of AD Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma" Allocation concealment (selection bias) Low risk Not described Comment: likely to be low risk since this is a large multicentre trial Blinding of participants and personnel (performance bias) All outcomes Low risk Identical placebo, and "the number taken were the same at each dose for all groups" Blinding of outcome assessment (detection bias) All outcomes Low risk Not described Incomplete outcome data (attrition bias) All outcomes Unclear risk An 80% completion (581/725). ..

    Selection:

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Random sequence generation (selection bias) , Low risk , "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma". .. Allocation concealment (selection bias) , Low risk , Not described Comment: likely to be low risk since this is a large multicentre trial.

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Adverse events Source of funding Novartis Pharma Declaration of interest Sponsored by Novartis Pharma Notes Main hypothesis: to assess the effects of rivastigmine on the core domains of AD Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma" Allocation concealment (selection bias) Low risk Not described Comment: likely to be low risk since this is a large multicentre trial Blinding of participants and personnel (performance bias) All outcomes Low risk Identical placebo, and "the number taken were the same at each dose for all groups" Blinding of outcome assessment (detection bias) All outcomes Low risk Not described Incomplete outcome data (attrition bias) All outcomes Unclear risk An 80% completion (581/725). ..

    Generated:

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Random sequence generation (selection bias) , Low risk , "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma". .. Allocation concealment (selection bias) , Low risk , Not described Comment: likely to be low risk since this is a large multicentre trial.

    Article Title: Rivastigmine for Alzheimer's disease
    Article Snippet: .. Adverse events Source of funding Novartis Pharma Declaration of interest Sponsored by Novartis Pharma Notes Main hypothesis: to assess the effects of rivastigmine on the core domains of AD Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "randomly allocated ... according to a computer generated randomisation code at Novartis Pharma" Allocation concealment (selection bias) Low risk Not described Comment: likely to be low risk since this is a large multicentre trial Blinding of participants and personnel (performance bias) All outcomes Low risk Identical placebo, and "the number taken were the same at each dose for all groups" Blinding of outcome assessment (detection bias) All outcomes Low risk Not described Incomplete outcome data (attrition bias) All outcomes Unclear risk An 80% completion (581/725). ..

    other:

    Article Title: Which drug is most effective in treating childhood tinea capitis caused by Microsporum species?
    Article Snippet: Design: Four double-blind duration-finding terbinafine arms were compared with an unblinded griseofulvin arm.. Each arm was parallel, and patients were randomly allocated.. The study duration was 12 weeks with a 4-week follow-up.



    Similar Products

    computer generated randomisation code  (Cipla Inc)
    90
    Cipla Inc computer generated randomisation code
    Computer Generated Randomisation Code, supplied by Cipla Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc06485805-575-2-18
    Average 90 stars, based on 1 article reviews
    computer generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation codes  (Pfizer Inc)
    90
    Pfizer Inc computer-generated randomisation codes
    Computer Generated Randomisation Codes, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+list/pmc06483741-2243-40-10
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation codes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer‑generated randomisation code  (Boehringer Ingelheim)
    90
    Boehringer Ingelheim computer‑generated randomisation code
    Bateman 2010a
    Computer‑Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc08934583-115-16-20
    Average 90 stars, based on 1 article reviews
    computer‑generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Boehringer Ingelheim)
    90
    Boehringer Ingelheim computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc10879916-322-16-20
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Ferring Pharmaceuticals)
    90
    Ferring Pharmaceuticals computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation/pmc11422753-1997-29-6
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation codes  (Bayer Schering Pharma)
    90
    Bayer Schering Pharma computer-generated randomisation codes
    Bateman 2010a
    Computer Generated Randomisation Codes, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+codes/pm18395326-57-0-7
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation codes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer generated randomisation code  (Pharmacia Upjohn LLC)
    90
    Pharmacia Upjohn LLC computer generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/patches+with+randomization+numbers/pmc01920563-139-7-17
    Average 90 stars, based on 1 article reviews
    computer generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Novartis)
    90
    Novartis computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pm12765508-76-17-21
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Bateman 2010a

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Bateman 2010a

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Medications, Clinical Proteomics, Sequencing, Selection

    Bateman 2010b

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Bateman 2010b

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

    Beeh 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Beeh 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Brusasco 2003

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Brusasco 2003

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Casaburi 2002

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Casaburi 2002

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Capsules

    Chan 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Chan 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Cooper 2010

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Cooper 2010

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Modification, Sequencing, Selection, Generated, Control

    Covelli 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Covelli 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Dusser 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Dusser 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Control

    Freeman 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Freeman 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated

    Johansson 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Johansson 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Magnussen 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Magnussen 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

    Moita 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Moita 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    NCT00144326

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: NCT00144326

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Activity Assay, Plasmid Preparation, Modification, Sequencing, Selection, Generated, Control

    Niewoehner 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Niewoehner 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated

    Powrie 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Powrie 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Concentration Assay, Sequencing, Selection, Generated, Control

    Tashkin 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Tashkin 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated

    Tonnel 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Tonnel 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay, Control

    Trooster 2011

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Trooster 2011

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Medications, Activity Assay, Sequencing, Selection, Generated, Control

    Verkinde 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Verkinde 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Modification, Sequencing, Selection, Generated, Control

    Voshaar 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Voshaar 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated

    Bateman 2010a

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Bateman 2010a

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Medications, Sequencing, Selection

    Brusasco 2003

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Brusasco 2003

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Calverley 2007 [TORCH]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Calverley 2007 [TORCH]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Western Blot, Biomarker Discovery, Solvent, Medications, Sequencing, Selection, Generated, Clinical Proteomics

    Niewoehner 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Niewoehner 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated, Modification

    Ohar 2013

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Ohar 2013

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection

    Ozol 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Ozol 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection, Generated

    Renkema 1996

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Renkema 1996

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Functional Assay, Clinical Proteomics, Sequencing, Selection

    Schermer 2009

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Schermer 2009

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection, Generated, Blocking Assay

    Tashkin 2008a [UPLIFT]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Tashkin 2008a [UPLIFT]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection

    Tonnel 2008 [TIPHON]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Tonnel 2008 [TIPHON]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay

    Vogelmeier 2011 [POET]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Vogelmeier 2011 [POET]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Blocking Assay, Capsules